Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide ophthalmic suspension versus Azopt for elevated intraocular pressure or open-angle glaucoma
2013-001793-21Phase 3Completed
- Sponsor
- Pharmathen
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brinzolamide in ocular hypertension and open-angle glaucoma (OAG) (2 arms), sponsored by Pharmathen. Started May 2013; status: completed.
02
Drugs
brinzolamide
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2013-001793-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001793-21.